- -

150 "

: Prezista 150 Mg. ?  »
|
-

PER OS

Film Coated Tablets

Adult Patients:Prezista, co-administered with ritonavir (Prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (HIV -1) infection. This indication is based on analyses of plasma HIV-1 RNA levels and CD4+ cell counts from 2 controlled phase 3 trials of 48 weeks duration in antiretroviral treatment - naive and treatment-experienced patients and 2 controlled phase 2 trials of 96 weeks duration in clinically advanced, treatment-experienced adult patients .Pediatric patients:Prezista, co-administered with ritonavir (Prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of HIV-1 infection in treatment-experienced pediatric patients 6 years of age and older .This indication is based on 24 Week analyses of plasma HIV-1 RNA levels and CD4+ cell counts from an open-label phase 2 trial in antiretroviral treatment-experienced pediatric patients 6 to

144 32 32992 00

Janssen Cilag S.p.a., Italy

09/2010 - 08/2015

.
, .
.
/
Darunavir as ethanolate 150 MG
Bottle hdpe 240 x TABLETS 36

*

*

 

.

? !
 »
 
" !
 

? !
 »
252